Medical Journals

Bcr/Abl and Il-3 Activate Rap1 to Stimulate the B-raf/Mek/Erk and Akt Signaling Pathways and to Regulate Proliferation, Apoptosis, and Adhesion.

Authors:
  • Jin A
  • Kurosu T
  • Tsuji K
  • Mizuchi D
  • Arai A
  • Fujita H
  • Hattori M
  • Minato N
  • Miura O

From: Department of Hematology, Tokyo Medical and Dental University, Japan.

Oncogene

  • Publish Date: Jul 2006
  • ISSN: 0950-9232
  • Volume: 25
  • Issue: 31
  • Pages: 4332-40
  • Medium: Print
  • Language: English
  • Citation (JAMA): Jin A, Kurosu T, Tsuji K, et al. Bcr/Abl and Il-3 Activate Rap1 to Stimulate the B-raf/Mek/Erk and Akt Signaling Pathways and to Regulate Proliferation, Apoptosis, and Adhesion.. Oncogene Jul 2006;25:4332-40

Abstract

The Ras family small GTPase Rap1 is activated by hematopoietic cytokines, such as interleukin (IL)-3, to induce beta1 integrin-mediated cell adhesion or by the BCR/ABL fusion tyrosine kinase to stimulate the MEK/Erk signaling pathway. Here, we demonstrate that the abrogation of Rap1 activation by SPA-1, a Rap1-specific GAP, inhibits activation of B-Raf, MEK, Erk, and Akt in a murine hematopoietic cell line, Ton.B210, stimulated with IL-3 or inducibly expressing BCR/ABL. Furthermore, Rap1 inactivation had an inhibitory effects on proliferation and survival of Ton.B210 cells, which were more remarkable when cells were stimulated by BCR/ABL than by IL-3. Induction of BCR/ABL expression increased adhesion of Ton.B210 cells to fibronectin in a manner at least partly dependent on its kinase activity, and Rap1 inhibition by SPA-1 partially inhibited BCR/ABL-induced adhesion of cells. Thus, IL-3- or BCR/ABL-induced activation of Rap1 may play important roles in regulation of cell proliferation and survival through activation of the B-Raf/MEK/Erk and Akt signaling pathways and in induction of integrin-mediated cell adhesion. Furthermore, as compared with IL-3, BCR/ABL is more dependent on Rap1-mediated signaling to induce cell proliferation and survival and, thus, Rap1 may represent an attractive target for novel therapies for leukemias caused by BCR/ABL.

Mesh Headings (Keywords): Animals, Apoptosis, Cell Adhesion, Cell Line, Cell Proliferation, Clone Cells, Extracellular Signal-Regulated MAP Kinases, Fusion Proteins, bcr-abl, Humans, Interleukin-3, K562 Cells, MAP Kinase Kinase 1, Mice, Proto-Oncogene Proteins B-raf, Proto-Oncogene Proteins c-akt, Signal Transduction, Tumor Cells, Cultured, rap1 GTP-Binding Proteins


Check for Full Text / PubMed Unique Identifier (PMID): 16518411


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.